Rheumatoid arthritis: vizsgálatok itt: Bulgária
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA clinical study to assess if a new investigational medicinal product called JJP-1212 is safe, tolerable and able to induce a specific immune response in humans
- Where
- Sofia
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- Jjp Biologics Sp. z o.o.
See details and how to join2023-508661-33-00 · EU 2023-508661-33-00 - 1. fázisTaking peopleA Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
- Where
- Sofia
- Életkor
- 18 év to 70 év
- People
- 36 worldwide
- Run by
- Jade Biosciences, Inc.
See details and how to joinNCT07533955 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Where
- Haskovo, Pleven, Sofia
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07276581 - 2. fázisTaking peopleA study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.
- Where
- Haskovo, Pleven, Sofia, Sofiya
- Életkor
- 18 év and over
- People
- 97 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-522076-85-00 · EU 2025-522076-85-00 - 1. fázisTaking peoplePhase 1 Single Dose Study of JADE201 in Participants with Rheumatoid Arthritis
- Where
- Sofiya
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- Jade Biosciences Inc.
See details and how to join2025-524746-96-00 · EU 2025-524746-96-00 - 2. fázisNot yet taking people in BulgáriaA study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
- Where
- Haskovo, Pleven, Plovdiv, Ruse, Sofia, Sofiya, Vratsa
- Életkor
- 18 év and over
- People
- 95 worldwide
- Run by
- Elevara Medicines Limited
See details and how to join2025-524005-32-00 · EU 2025-524005-32-00 - 2. fázisTaking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Plovdiv, Sofia
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - 1. fázisTaking peopleA phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
- Where
- Sofiya
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-520196-27-00 · EU 2024-520196-27-00 - 2. fázisTaking peopleA Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
- Where
- Sofia, Vratsa
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- SynAct Pharma Aps
See details and how to joinNCT06671054 - 1. fázisNot yet taking people in BulgáriaA Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pimozide after Multiple Dose Administration in Subjects with Rheumatoid Arthritis
- Where
- Sofiya
- Életkor
- 18 év and over
- People
- 24
- Run by
- Generos Biopharma Ltd.
See details and how to join2023-507521-41-01 · EU 2023-507521-41-01